BKV (NYSE:BKV) Given New $32.00 Price Target at Citigroup

BKV logo with Energy background
Image from MarketBeat Media, LLC.

Key Points

  • Citigroup raised its BKV price target to $32 from $31 and maintained a Buy rating, implying 67% upside from the stock’s then-current price of $19.16.
  • Analyst sentiment is broadly positive: BKV has a consensus “Moderate Buy” rating and an average price target of $33, based on one Strong Buy, eight Buy, and two Hold ratings.
  • BKV’s latest quarter showed mixed results: EPS of $0.36 missed the $0.38 consensus, while revenue of $478.37 million exceeded analysts’ $395.18 million estimate.
  • MarketBeat previews the top five stocks to own by December 1st.

BKV (NYSE:BKV - Get Free Report) had its target price increased by Citigroup from $31.00 to $32.00 in a research note issued on Tuesday, Benzinga reports. The firm presently has a "buy" rating on the stock. Citigroup's price objective points to a potential upside of 67.02% from the company's current price.

Several other brokerages also recently issued reports on BKV. Weiss Ratings downgraded shares of BKV from a "hold (c+)" rating to a "hold (c)" rating in a research note on Friday, October 23rd. Susquehanna dropped their price objective on BKV from $37.00 to $35.00 and set a "positive" rating on the stock in a research note on Tuesday, July 21st. Evercore raised BKV to a "strong-buy" rating in a research report on Friday, September 18th. Raymond James Financial set a $29.00 target price on BKV in a research note on Tuesday, September 15th. Finally, Barclays decreased their target price on BKV from $36.00 to $33.00 and set an "overweight" rating on the stock in a report on Friday. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $33.00.

Read Our Latest Research Report on BKV

BKV Stock Up 1.5%

BKV traded up $0.29 during trading on Tuesday, reaching $19.16. 199,084 shares of the stock were exchanged, compared to its average volume of 1,187,132. The company has a debt-to-equity ratio of 0.83, a quick ratio of 3.18 and a current ratio of 3.25. The stock's 50 day moving average price is $21.88 and its two-hundred day moving average price is $26.06. BKV has a twelve month low of $17.47 and a twelve month high of $32.81. The stock has a market cap of $2.07 billion, a P/E ratio of 9.08 and a beta of 1.13.

BKV (NYSE:BKV - Get Free Report) last announced its quarterly earnings data on Thursday, November 5th. The company reported $0.36 EPS for the quarter, missing analysts' consensus estimates of $0.38 by ($0.02). The firm had revenue of $478.37 million during the quarter, compared to the consensus estimate of $395.18 million. BKV had a net margin of 12.87% and a return on equity of 6.12%. Equities analysts expect that BKV will post 1.37 EPS for the current year.

Insider Transactions at BKV

In other news, CFO David Tameron sold 4,321 shares of the business's stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $26.56, for a total transaction of $114,765.76. Following the completion of the sale, the chief financial officer owned 58,524 shares in the company, valued at $1,554,397.44. The trade was a 6.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, SVP Javier Hinojosa sold 12,377 shares of the business's stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $25.73, for a total value of $318,460.21. Following the sale, the senior vice president owned 84,276 shares of the company's stock, valued at approximately $2,168,421.48. This represents a 12.81% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last quarter, insiders sold 30,578 shares of company stock worth $743,536. 2.51% of the stock is owned by company insiders.

Institutional Trading of BKV

Several hedge funds have recently added to or reduced their stakes in BKV. State of Alaska Department of Revenue boosted its stake in BKV by 23.1% in the 3rd quarter. State of Alaska Department of Revenue now owns 4,160 shares of the company's stock valued at $88,000 after purchasing an additional 782 shares during the period. Covestor Ltd increased its position in BKV by 36.4% during the 3rd quarter. Covestor Ltd now owns 3,454 shares of the company's stock worth $74,000 after buying an additional 921 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in BKV by 37.1% during the 2nd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 30,084 shares of the company's stock worth $823,000 after buying an additional 8,144 shares during the period. HighTower Advisors LLC lifted its holdings in shares of BKV by 33.6% during the third quarter. HighTower Advisors LLC now owns 33,043 shares of the company's stock worth $705,000 after buying an additional 8,308 shares in the last quarter. Finally, PEAK6 LLC acquired a new stake in shares of BKV during the second quarter worth $270,000.

About BKV

(Get Free Report)

BKV Corporation is a U.S. energy company focused on natural gas production and related businesses. It operates in the Barnett Shale in Texas and the Marcellus Shale in Pennsylvania, producing natural gas for sale to customers and markets across the region. The company has expanded beyond production into natural gas gathering and processing, natural gas-fired power generation, and carbon capture and sequestration. These activities connect its gas operations with energy delivery and projects intended to reduce emissions.

Recommended Stories

Analyst Recommendations for BKV (NYSE:BKV)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in BKV Right Now?

Before you consider BKV, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BKV wasn't on the list.

While BKV currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines